ScreenerHero

PWR Captiva Verde Wellness Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic
0.1000CAD0.00%Mkt Cap: 22.22M $P/E: —

Captiva Verde Wellness Corp. operates as a real estate company. It also invests in sports. The company was formerly known as Captiva Verde Land Corp. and changed its name to Captiva Verde Wellness Corp. in May 2021. Capt…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap22.22M USD
Enterprise Value21.56M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-755.54K USD
Revenue/Share—
Last Price0.1000 CAD
Fiscal Year EndOct 2025
MR QuarterJul 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA14076P1045
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B16.67
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.020094% of range0.1050
52W High0.1050 CAD
52W Low0.0200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-54.11%
ROA-23.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-715.92K USD
CapEx (TTM)21.85K USD
FCF Margin—
FCF Yield-1.55%
Net Debt-658.04K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.97
Quick Ratio0.32
Book Value/Sh0.0060 CAD
Cash/Share0.0030 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.305.13M
Float291.31M
Insiders2.83%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short758
Short (prev mo.)10.27K
Technical
SMA 500.0649 (+54.1%)
SMA 2000.0473 (+111.5%)
Beta0.76
S&P 52W Chg16.45%
Avg Vol (30d)142.63K
Avg Vol (10d)173.31K
Technical Indicators
RSI (14)69.2
MACD0.0160
MACD Signal0.0149
MACD Hist.+0.0011
BB Upper0.1371 CAD
BB Middle0.0755 CAD
BB Lower0.0140 CAD
BB Width163.05%
ATR (14)0.0079 CAD
Vol Ratio (20d)0.34x